Active Biotech
Active Biotech: New Results from Naptumomab (Redeye)
2024-05-28 09:44
Redeye comments on the readout from the phase IIa study of naptumomab in combination with docetaxel in lung cancer conducted by NeoTX.
info@redeye.se (Redeye.se)
Redeye AB - Redeye.se